SPY

Entera May Be the 1st Winner of FDA’s New Framework Redefining the Multi Billion Dollar Osteoporosis Market

Posted by on | Featured

WSW, NY, 23rd March 2026, FinanceWire … Read More

Tags: , , , , , , , , ,

Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)

Posted by on | Featured

WSW, NY, 20th March 2026, FinanceWire … Read More

Tags: , , , , , , , , ,

Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)

Posted by on | Featured

WSW, NY, 20th March 2026, FinanceWire … Read More

Tags: , , , , , , , , , ,

Duke Robotics Lands $1M+ Contract as Trump’s $1.9B Initiative Creates Tailwind Drone Innovator (OTCQB: DUKRD)

Posted by on | Featured

WSW, NY, 19th March 2026, FinanceWire … Read More

Tags: , , , , , , , ,

Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)

Posted by on | Featured

WSW, NY, 19th March 2026, FinanceWire … Read More

Tags: , , , , , , , ,

PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention

Posted by on | Featured

WSW, NY, 18th March 2026, FinanceWire … Read More

Tags: , , , , , , ,

Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform

Posted by on | Featured

WSW, NY, 16th March 2026, FinanceWire … Read More

Tags: , , , , , , ,

Duke Robotics Could Be One of the Underdog Companies Emerging From Israel’s Drone Tech Boom (OTCQB: DUKRD)

Posted by on | Featured

WSW, NY, 12th March 2026, FinanceWire … Read More

Tags: , , , , , , , ,

Duke Robotics May Be the Most Overlooked Drone Player in the Israeli Defense Boom (OTCQB: DUKR)

Posted by on | Featured

WSW, NY, 5th March 2026, FinanceWire … Read More

Tags: , , , , ,

Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)

Posted by on | Featured

WSW, NY, 5th March 2026, FinanceWire … Read More

Tags: , , , , , ,